A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Medetomidine Impurity 11 - Request Quote

Picture of Medetomidine Impurity 11

Medetomidine Impurity 11

SZ CAT No:SZ-M070036
CAS No
NA
Mol.F.
C13H16N2 : HCl
Mol.Wt.
200.3 : 36.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Medetomidine Impurity 11 is chemically 4-(1-(2,6-Dimethylphenyl)ethyl)-1H-imidazole hydrochloride. Medetomidine Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Medetomidine Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Medetomidine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Medetomidine Impurity 11

Purchase Medetomidine Impurity 11

Medetomidine Impurity 11 suppliers

Medetomidine Impurity 11 manufacturers

Medetomidine Impurity 11 price

Order Medetomidine Impurity 11

Enquire Medetomidine Impurity 11

Medetomidine Impurity 11 cost

Medetomidine Impurity 11 Supplier

Medetomidine Impurity 11 Distributor

Medetomidine Impurity 11 for Method Validation

Medetomidine Reference Standard

Medetomidine Impurity 11 for ANDA Filing

Medetomidine Impurity 11 for Forced Degradation Studies

Medetomidine Impurity 11 Identification Standards

Medetomidine Impurity 11 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,